Evidence map›Paper›PMID 34272385›Full record

ArticleNature communications2021

Abraxas suppresses DNA end resection and limits break-induced replication by controlling SLX4/MUS81 chromatin loading in response to TOP1 inhibitor-induced DNA damage.

Xiao Wu, Bin Wang

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Mechanisms and genomic implications of break-induced replication.Nature structural & molecular biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xiao WuDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bin WangDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. bwang3@mdanderson.org.ORCID 0000-0003-3352-6992
The University of Texas MD Anderson Cancer Center · US

Funding

The role of a novel BRCA1 associated complex in DNA damage response and tumor supR01CA155025 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WANG, BIN · 2011 to 2020
$3.4M
Coordination of DNA repair and transcription by ubiquitin modification at DNA double strand breaksR01CA248088 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WANG, BIN · 2020 to 2024
$1.8M
NCI NIH HHS R01 CA155025NCI NIH HHS R01 CA248088
6 · The paper itself

Abstract

Although homologous recombination (HR) is indicated as a high-fidelity repair mechanism, break-induced replication (BIR), a subtype of HR, is a mutagenic mechanism that leads to chromosome rearrangements. It remains poorly understood how cells suppress mutagenic BIR. Trapping of Topoisomerase 1 by camptothecin (CPT) in a cleavage complex on the DNA can be transformed into single-ended double-strand breaks (seDSBs) upon DNA replication or colliding with transcriptional machinery. Here, we demonstrate a role of Abraxas in limiting seDSBs undergoing BIR-dependent mitotic DNA synthesis. Through counteracting K63-linked ubiquitin modification, Abraxas restricts SLX4/Mus81 recruitment to CPT damage sites for cleavage and subsequent resection processed by MRE11 endonuclease, CtIP, and DNA2/BLM. Uncontrolled SLX4/MUS81 loading and excessive end resection due to Abraxas-deficiency leads to increased mitotic DNA synthesis via RAD52- and POLD3- dependent, RAD51-independent BIR and extensive chromosome aberrations. Our work implicates Abraxas/BRCA1-A complex as a critical regulator that restrains BIR for protection of genome stability.

Indexed as

AnimalsCamptothecinCarrier ProteinsCell Line, TumorCell SurvivalChromatinDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA Polymerase IIIDNA ReplicationDNA Topoisomerases, Type IEndonucleasesHomologous RecombinationHumansMiceABRAXAS1 protein, humanCamptothecinCarrier ProteinsChromatinDNA-Binding ProteinsDNA Polymerase IIIDNA Topoisomerases, Type IEndonucleasesMRE11 Homologue ProteinMRE11 protein, humanMUS81 protein, humanPOLD3 protein, humanRad52 DNA Repair and Recombination ProteinRAD52 protein, humanRecombinasesRNA, Small InterferingSLX4 protein, humanTOP1 protein, humanTopoisomerase I Inhibitors

Identifiers

PMID34272385
PMCPMC8285526
OpenAlexW3179484154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.